Literature DB >> 6403940

Use of synthetic oligonucleotide probes complementary to genes for human HLA-DR alpha and beta as extension primers for the isolation of 5'-specific genomic clones.

H K Das, P A Biro, S N Cohen, H A Erlich, A von Gabain, S K Lawrance, P G Lemaux, H O McDevitt, B M Peterlin, M F Schulz, A K Sood, S M Weissman.   

Abstract

We have synthesized 175-nucleotide-long probes for the DNA of human histocompatibility antigens HLA-DR alpha and beta by extending on poly(A)+ mRNA from B-cell lines with short synthetic deoxyribonucleotide primers complementary to the predicted nucleotide sequence of the NH2 terminus of both polypeptides. The synthesis of the probe for the alpha-chain DNA was a two-step process starting with 11-mers which were extended by dideoxynucleotide chain termination experiments to a 20-mer of predicted sequence. The synthesized 20-mer was then used to generate a 175-nucleotide cDNA probe which was shown to encode the appropriate amino acids for the alpha chain and was used to select a human genomic DNA clone containing the coding sequences for HLA-DR alpha. For the beta polypeptide an 18-mer homologous to the NH2-terminal sequence of a cDNA clone from another B-cell line was used to extend on poly(A)+ mRNA isolated from a B-cell line. Preliminary sequence analysis of a 175-base-long extension product indicates a match of the cDNA sequence to the published sequence of a clone for HLA-DR beta. Information from these extension experiments helps to establish the sensitivity and specificity of the primer extension method.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403940      PMCID: PMC393635          DOI: 10.1073/pnas.80.6.1531

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  The major histocompatibility complex of the mouse.

Authors:  J Klein
Journal:  Science       Date:  1979-02-09       Impact factor: 47.728

2.  A rapid and convenient synthesis of poly-thymidylic acid by the modified triester approach.

Authors:  A K Sood; S A Narang
Journal:  Nucleic Acids Res       Date:  1977-08       Impact factor: 16.971

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Charon phages: safer derivatives of bacteriophage lambda for DNA cloning.

Authors:  F R Blattner; B G Williams; A E Blechl; K Denniston-Thompson; H E Faber; L Furlong; D J Grunwald; D O Kiefer; D D Moore; J W Schumm; E L Sheldon; O Smithies
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

5.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

6.  The isolation of structural genes from libraries of eucaryotic DNA.

Authors:  T Maniatis; R C Hardison; E Lacy; J Lauer; C O'Connell; D Quon; G K Sim; A Efstratiadis
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

7.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

Review 8.  Expression of Ia antigens on T and B cells and their relationship to immune-response functions.

Authors:  J E Niederhuber; J A Frelinger
Journal:  Transplant Rev       Date:  1976

9.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

Review 10.  Determinant selection and macrophage function in genetic control of the immune response.

Authors:  A S Rosenthal
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

View more
  9 in total

1.  Identification and nucleotide sequence of the delta-lysin gene, hld, adjacent to the accessory gene regulator (agr) of Staphylococcus aureus.

Authors:  L Janzon; S Löfdahl; S Arvidson
Journal:  Mol Gen Genet       Date:  1989-11

2.  The genomic organisation and nucleotide sequence of the HLA-SB(DP) alpha gene.

Authors:  S K Lawrance; H K Das; J Pan; S M Weissman
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

3.  DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype.

Authors:  J I Bell; P Estess; T St John; R Saiki; D L Watling; H A Erlich; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  Structure and nucleotide sequence of the heavy chain gene of HLA-DR.

Authors:  H K Das; S K Lawrance; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Transcriptional activation of HLA-DR alpha by interferon gamma requires a trans-acting protein.

Authors:  M A Blanar; E C Boettger; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Characterization of mouse myelin basic protein messenger RNAs with a myelin basic protein cDNA clone.

Authors:  N K Zeller; M J Hunkeler; A T Campagnoni; J Sprague; R A Lazzarini
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Gamma interferon and 5-azacytidine cause transcriptional elevation of class I major histocompatibility complex gene expression in K562 leukemia cells in the absence of differentiation.

Authors:  E Chen; R W Karr; J P Frost; T A Gonwa; G D Ginder
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

8.  Isolation and partial nucleotide sequence of the laccase gene from Neurospora crassa: amino acid sequence homology of the protein to human ceruloplasmin.

Authors:  U A Germann; K Lerch
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  SB subregion of the human major histocompatibility complex: gene organization, allelic polymorphism and expression in transformed cells.

Authors:  K Okada; H L Prentice; J M Boss; D J Levy; D Kappes; T Spies; R Raghupathy; R A Mengler; C Auffray; J L Strominger
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.